CompanyDrug

Luye Pharma Launches Named Patient Program for Lurbinectedin in Hong Kong

CompanyDrug

Innovent Biologics Doses First Patient in Phase III Study for Mazdutide

Policy / Regulatory

China Meheco Keyi Pharma’s Ganciclovir Loses VBP Bid After Inspection Failure

Policy / Regulatory

NMPA Releases 63rd Batch of Reference Drugs for Generic Quality Evaluation

CompanyDrug

Cosunter’s COVID-19 Drug GST-HG171 Shows Superior Efficacy in Trial

CompanyDrug

Fosun Foundation Donates COVID-19 Therapy Azvudine to Rural China

Policy / Regulatory

NMPA Approves Expanded Production for COVID-19 Symptom Treatments

CompanyDrug

Roche’s Glofitamab and Dizal’s Sunvozertinib Enter Priority Review

CompanyDeals

Yinjia Biosciences Raises RMB 100 Million in Series A Financing Round

Policy / Regulatory

China Optimizes Medical Insurance Policies for COVID-19 Treatment

CompanyDeals

China Resources Biopharmaceutical Secures RMB 600 Million in Series B Funding

CompanyDrug

Adagene’s ADG126 Shows Promise in Combination with Anti-PD-1 Therapy